The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives

Elżbieta Jodłowska; Rafał Czepczyński; Agata Czarnywojtek; Amanda Rewers; Grażyna Jarząbek; Witold Kędzia; Marek Ruchała

doi:10.5114/wo.2016.61560

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2016
vol. 20

Send email

Copy url:

abstract:

Review paper

The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives

Elżbieta Jodłowska

,

Rafał Czepczyński

,

Agata Czarnywojtek

,

Amanda Rewers

,

Grażyna Jarząbek

,

Witold Kędzia

,

Marek Ruchała

Contemp Oncol (Pozn) 2016; 20 (3): 205-209

DOI: https://doi.org/10.5114/wo.2016.61560

Online publish date: 2016/08/04

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Jodłowska E, Czepczyński R, Czarnywojtek A, et al. The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives. Contemporary Oncology/Współczesna Onkologia. 2016;20(3):205-209. doi:10.5114/wo.2016.61560.

APA

Jodłowska, E., Czepczyński, R., Czarnywojtek, A., Rewers, A., Jarząbek, G.,  & Kędzia, W. et al. (2016). The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives. Contemporary Oncology/Współczesna Onkologia, 20(3), 205-209. https://doi.org/10.5114/wo.2016.61560

Chicago

Jodłowska, Elżbieta, Rafał Czepczyński, Agata Czarnywojtek, Amanda Rewers, Grażyna Jarząbek, Witold Kędzia,  and Marek Ruchała. 2016. "The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives". Contemporary Oncology/Współczesna Onkologia 20 (3): 205-209. doi:10.5114/wo.2016.61560.

Harvard

Jodłowska, E., Czepczyński, R., Czarnywojtek, A., Rewers, A., Jarząbek, G., Kędzia, W.,  and Ruchała, M. (2016). The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives. Contemporary Oncology/Współczesna Onkologia, 20(3), pp.205-209. https://doi.org/10.5114/wo.2016.61560

MLA

Jodłowska, Elżbieta et al. "The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives." Contemporary Oncology/Współczesna Onkologia, vol. 20, no. 3, 2016, pp. 205-209. doi:10.5114/wo.2016.61560.

Vancouver

Jodłowska E, Czepczyński R, Czarnywojtek A, Rewers A, Jarząbek G, Kędzia W et al. The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives. Contemporary Oncology/Współczesna Onkologia. 2016;20(3):205-209. doi:10.5114/wo.2016.61560.

PlumX metrics:

Similarly to the applications described in the first part of this publication, positron emission tomography with computed tomography (PET/CT) is also gaining importance in monitoring a tumour’s response to therapy and diagnosing breast cancer recurrences. This is additionally caused by the fact that many new techniques (dual-time point imaging, positron emission tomography with magnetic resonance PET/MR, PET/CT mammography) and radiotracers (16α-18F-fluoro-17β-estradiol, 18F-fluorothymidine) are under investigation. The highest sensitivity and specificity when monitoring response to treatment is achieved when the PET/CT scan is made after one or two chemotherapy courses. Response to anti-hormonal treatment can also be monitored, also when new radiotracers, such as FES, are used. When monitoring breast cancer recurrences during follow-up, PET/CT has higher sensitivity than conventional imaging modalities, making it possible to monitor the whole body simultaneously. New techniques and radiotracers enhance the sensitivity and specificity of PET and this is why, despite relatively high costs, it might become more widespread in monitoring response to treatment and breast cancer recurrences.

keywords:

The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives

Elżbieta Jodłowska , Rafał Czepczyński , Agata Czarnywojtek , Amanda Rewers , Grażyna Jarząbek , Witold Kędzia , Marek Ruchała

breast cancer, positron emission tomography, computed tomography, radiopharmaceuticals

Elżbieta Jodłowska

,

Rafał Czepczyński

,

Agata Czarnywojtek

,

Amanda Rewers

,

Grażyna Jarząbek

,

Witold Kędzia

,

Marek Ruchała